10 studies found for:    Open Studies | "Influenza in Birds"
Show Display Options
Rank Status Study
1 Recruiting A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine
Conditions: Bird Flu;   Avian Influenza;   Influenza A(H5N1)
Intervention: Biological: AT-301
2 Not yet recruiting Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
Condition: Pandemic Avian (H5N1) Influenza
Intervention: Biological: GSK1557484A vaccine
3 Recruiting Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults
Condition: Pandemic H5N1 Influenza
Intervention: Biological: Adjuvanted H5N1 pandemic influenza vaccine
4 Recruiting Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
Condition: Pandemic H5N1 Influenza
Intervention: Biological: Adjuvanted H5N1 pandemic influenza vaccine
5 Recruiting Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
Condition: Pandemic H5N1 Influenza
Intervention: Biological: Adjuvanted H5N1 pandemic influenza vaccine
6 Recruiting Immunogenicity of ND1.1 by Delivery Directly to the Ileum
Condition: Avian Influenza
Intervention: Biological: ND1.1
7 Recruiting Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
Condition: H5N1 Influenza
Interventions: Biological: Ad4-H5-VTN vaccination-tonsillar route;   Biological: Ad4-H5-vaccination-oral route
8 Recruiting Immune Responses to H5N1 Vaccine With and Without MF59 Adjuvant
Conditions: Influenza;   Healthy
Interventions: Biological: H5N1 vaccine plus MF59 adjuvant;   Biological: H5N1 vaccine without adjuvant
9 Recruiting Blood and Plasma Collection For Use in Future H1N1 (Swine Flu) Clinical Trials
Condition: Influenza A Subtype H5N1 Infection
Intervention: Biological: Collection of Anti-Influenza A/H1N1 Immune Plasma
10 Recruiting Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)

Indicates status has not been verified in more than two years